Loading
Earnings sentiment for Biotechnology — aggregated from 7 earnings calls in the Healthcare sector
As of 2026 Q1, the Tellvest aggregate earnings-call sentiment for the Biotechnology industry is 7.3/10 across 7 companies.
Aggregated from 7 earnings calls
A composite score derived from averaging overall earnings sentiment across all analyzed companies in this industry for their latest reported quarter. Score is 0–10 (10 = most positive).
The industry average sentiment score edged up from 7 to 7.29, but the aggregate hides an unusually violent reshuffling underneath it: five of seven companies moved, and the two largest moves went in opposite directions. Moderna jumped from 3 to 8 and Regeneron from 4 to 7, while Vertex fell from 9 to 6. Pricing pressure disappeared as a theme entirely, going from 2 companies to 0, even as cost pressure ticked up from 4 to 5.
| Signal | Companies | Direction breakdown |
|---|---|---|
| Regulation Policy | 5 | 221 |
| Consumer Demand | 3 | 21 |
% change over the trailing year, log scale. 1Y and YTD are each name’s own price return. Equal-weight: average of every full-history member, weighted equally, not rebalanced.